Global Oral Solid Dosage Excipients Market, By Product Type (Glycerin, Propylene Glycol, Sorbitol, Mannitol and Others), By Form (Crystal, Powder and Others), By Application (Industrial and Non-Industrial) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI463821 | Publish Date: August 2023 | No. of Pages: 168

Global Oral Solid Dosage Excipients Market Overview

Pharmaceuticals industries are the wide and essential industries. Excipients are a part of the pharmaceutical industry and their demand is expected to increase over the forecast period. This is due to their ability to perform various functions such as improving the modifying drug release, stability of the active pharmaceutical ingredient (API) and masking taste. Expanding patient base and developing cost-effective drugs has led to the growth of generics. Moreover, the need for excipients has increased which can be successfully utilized for these drugs. Furthermore, excipients exhibit no medicinal properties to the drug; they have a well-defined role ranging from protecting the API to easing the manufacturing process. Factors such as patent expiration of blockbuster drugs, which consequently boost the need for generic drugs, and increasing demand for patient-compliant drugs have boosted the demand for oral solid dosage excipients. However, stringent regulatory process is one of the roadblocks for the development of novel excipients. Long development process, huge investment into R&D, and chances of failure have prevented manufacturers from developing novel excipients.

Impact of Covid-19 pandemic on market

The decline in this market is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving remote working, social distancing and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disturbed, impacting the market negatively.

Global Oral Solid Dosage Excipients Market Dynamics

Increasing Demand for Environmentally Friendly Excipients to Drive the Growth of the Market

Continuous manufacturing technology has gained prominence in the market. Although traditional processes are incorporated in the continuous process line, the requirement of ingredients differs. Therefore, there is a need for excipients that are also well suited for the continuous process. Rising geriatric, children and mentally-disabled population has increased the demand for flexible oral dosage formulations including chewable tablets and lozenges.  Furthermore, with the influx of such flexible oral solid dosage formations, the demand for excipients compatible with them has subsequently increased driving the market

Difficulty and time consuming process involved for manufacturing

The oral solid doses excipient industries faces some competition from injectable doses industries because of the increasingly difficult-to-formulate Active Pharmaceutical Ingredient (APIs) in the drug pipeline.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Oral Solid Dosage Excipients Market Segmentation

 

Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

Source: Prophecy Market Insights

 

He Global Oral Solid Dosage Excipients Market is segmented based on product type, form, application, and region. By Product Type, Global Oral Solid Dosage Excipients Market is segmented into Glycerin, Propylene Glycol, Sorbitol, Mannitol and Others. By Form, the market is segmented in Crystal, Powder and Others. By Application, Global Oral Solid Dosage Excipients Market is segmented into Industrial and Non-Industrial.

 

Regional Insights:

Based on region, the Global Oral Solid Dosage Excipients Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has dominated the oral solid dosage excipients market and is expected to sustain this position during the forecast period. Furthermore, strong economic growth increases the affordability quotient, which results in an increased demand for better healthcare services in the region.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

 

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Product type- Glycerin, Propylene Glycol, Sorbitol, Mannitol and Others

 By Form– Crystal, Powder and Others

By Application– Industrial, Non-Industrial

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the Global Oral Solid Dosage Excipients Market report based on product type, form, application, and region.

 

Global Oral Solid Dosage Excipients Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Oral Solid Dosage Excipients Market Key Players

The key players operating in the Global Oral Solid Dosage Excipients Market includes AstraZeneca Plc., Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Novartis AG, Pfizer Inc., AbbVie Inc., Boehringer Ingelheim GmbH, Hoffman-La-Roche Ltd., Johnson and Johnson, Biogen Inc., Bayer AG, Teva Pharmaceuticals, Amgen Inc., Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Shire Plc., Celgene Corporation, Astellas Pharma Inc. Companies are continuously rising the production and supply of excipient dosage. Evonik, a German specialty pharmaceuticals company, announced on Dec. 7, 2020 that it has signed an agreement to acquire the LACTEL business of biodegradable polymers from DURECT for US $15 million.

Global Oral Solid Dosage Excipients Market Company Profile

  • Merck and Co. Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca Plc.
  •  Bristol-Myers Squibb Company
  •  Eli Lilly and Company
  • Gilead Sciences
  •  Novartis AG
  •  Pfizer Inc.
  •  AbbVie Inc.
  •  Boehringer Ingelheim GmbH
  •  Hoffman-La-Roche Ltd.
  •  Johnson and Johnson
  • Biogen Inc.
  • Bayer AG
  • Teva Pharmaceuticals
  • Amgen Inc.
  • Takeda Pharmaceutical Company Ltd.
  •  Otsuka Pharmaceutical Co.
  •  Ltd.
  •  Shire Plc.
  •  Celgene Corporation
  • Astellas Pharma Inc.

 “*” marked represents similar segmentation in other categories in the respective section

Global Oral Solid Dosage Excipients Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for oral solid dosage excipients Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product Type
      • Market Snippet, By Form
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Oral Solid Dosage Excipients Market, By Product Type 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Glycerin
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Propylene Glycol
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Sorbitol
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Mannitol
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

 

  1. Global Oral Solid Dosage Excipients Market, By Form 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Crystal
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Powder
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

 

  1. Global Oral Solid Dosage Excipients Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Industrial
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Non-Industrial
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

 

  1. Global Oral Solid Dosage Excipients Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Form, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Form, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Form, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Form, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Form, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  2. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  3. Company Profiles
  • Merck and Co. Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca Plc.
  •  Bristol-Myers Squibb Company
  •  Eli Lilly and Company
  • Gilead Sciences
  •  Novartis AG
  •  Pfizer Inc.
  •  AbbVie Inc.
  •  Boehringer Ingelheim GmbH
  •  Hoffman-La-Roche Ltd.
  •  Johnson and Johnson
  • Biogen Inc.
  • Bayer AG
  • Teva Pharmaceuticals
  • Amgen Inc.
  • Takeda Pharmaceutical Company Ltd.
  •  Otsuka Pharmaceutical Co.
  •  Ltd.
  •  Shire Plc.
  •  Celgene Corporation
  • Astellas Pharma Inc.
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

 

FAQs

The Global Oral Solid Dosage Excipients Market is segmented based on product type, form, application and region.

Continuous improvements in technology and custom dosage production are the major factor driving growth of the global market

North America has dominated the oral solid dosage excipients market and is expected to sustain this position during the forecast period. Furthermore, strong economic growth increases the affordability quotient, which results in an increased demand for better healthcare services in the region.